19-40366857-G-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_012268.4(PLD3):c.187G>A(p.Gly63Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000748 in 1,613,978 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_012268.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLD3 | NM_012268.4 | c.187G>A | p.Gly63Ser | missense_variant | 5/13 | ENST00000409735.9 | NP_036400.2 | |
PLD3 | NM_001031696.4 | c.187G>A | p.Gly63Ser | missense_variant | 5/13 | NP_001026866.1 | ||
PLD3 | NM_001291311.2 | c.187G>A | p.Gly63Ser | missense_variant | 5/13 | NP_001278240.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLD3 | ENST00000409735.9 | c.187G>A | p.Gly63Ser | missense_variant | 5/13 | 1 | NM_012268.4 | ENSP00000386938.3 |
Frequencies
GnomAD3 genomes AF: 0.000868 AC: 132AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000999 AC: 251AN: 251132Hom.: 3 AF XY: 0.00106 AC XY: 144AN XY: 135728
GnomAD4 exome AF: 0.000737 AC: 1077AN: 1461748Hom.: 5 Cov.: 31 AF XY: 0.000785 AC XY: 571AN XY: 727178
GnomAD4 genome AF: 0.000861 AC: 131AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.000900 AC XY: 67AN XY: 74416
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | PLD3: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 02, 2023 | - - |
PLD3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at